Results 171 to 180 of about 27,101 (268)

Skin Boosters: 2026 Updated

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Skin boosters are increasingly used to improve dermal quality through injectable and device‐assisted approaches; however, definitions and clinical evidence remain heterogeneous. Aims To provide an updated overview and propose a practical classification of skin boosters, including mechanisms, delivery methods, clinical outcomes, and limitations.
Kyu‐ho Yi, Hyunggyu Kang, Jong Keun Song, Olena Sydorchuk, Jeremy B. Green, Hugues Cartier, Roya Zarmehr Zamin, Benjamin Ascher   +7 more
wiley   +1 more source

Cold atmospheric plasma (CAP) stimulates melanoblast-to-melanocyte differentiation via PRKCQ upregulation and NF-κB activation. [PDF]

iScience
Zeng Y, Pan R, Li D, Nie L, Nie X, Wei Y, Lu X, Deng Y.   +7 more
europepmc   +1 more source

Treatment of Acne‐Induced Facial Post‐Inflammatory Hyperpigmentation With a New 2‐MNG‐Containing Routine Versus a Thiamidol‐Containing Routine—A Monocentric Prospective Double‐Blind Randomized Comparative Trial

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Acne‐induced post‐inflammatory hyperpigmentation (PIHP) is a frequent condition. 2‐mercaptonicotinoyl glycine (2‐MNG) is an innovative anti‐pigmenting molecule. Aims The aim of this study is to compare the efficacy and tolerability of two routines in the treatment of PIHP: 2‐MNG‐containing serum + SPF50+/UVA sunscreen versus ...
Thierry Passeron, Guénaëlle Le Dantec, Samir Salah, Beatrice Marie, Kate Randamy, Kim T. F. C. Dhin‐Kien, Ann' Laure Demessant‐Flavigny, Andrew Alexis   +7 more
wiley   +1 more source

Innovations in Refractory Melasma: Mechanism-Based Management and Emerging Therapeutic Strategies. [PDF]

Cureus
Laguna Rocafort S, Rivera-Díaz J, Bonilla IM, Rabelo-Cartagena J.   +3 more
europepmc   +1 more source

Evaluation of a Dermocosmetic Serum for Managing Hyperpigmentation Disorders in Phototypes IV‐VI Individuals From South Africa and Argentina

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Hyperpigmentation disorders are a distressing condition, especially for individuals with skin of color who are at higher risk. Often treated topically, a significant advancement in this field was Kligman's depigmenting trio, inhibiting melanogenesis, providing anti‐inflammatory benefits, and promoting epidermal renewal.
Susanna Margaretha H. Kannenberg, Alejandra Piegari Feliu, Shantal Valdés, Sandrine Bergera‐Virassamynaïk, Benoît Cadars, Audrey Gerstel, Arnaud Fontbonne, Sandra Trompezinski, Elodie Valin, Elodie Prestat‐Marquis   +9 more
wiley   +1 more source

Structural transformation of a hydrogel-forming cell division protein ZapB of multidrug resistant Klebsiella pneumoniae with small molecules. [PDF]

PLoS One
Khan A, Choudhary MI, Javaid S, Zafar H, Maslennikov I, Wahab AT.   +5 more
europepmc   +1 more source

Cucumber‐Derived Exosome‐Like Vesicles With Melanin‐Inhibitory Activity and an Acceptable in Vitro Safety Profile

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Skin hyperpigmentation disorders affect millions worldwide, driving demand for depigmentation products. However, many conventional skin‐lightening products contain dangerous ingredients, including mercury and unregulated hydroquinone.
Che‐Yuan Hsu, Wei‐Chen Chen, Horng‐Shen Chen, Yu‐Chen Liao, Cheng‐Han Hsieh, Donald Liu, Ya‐Wen Cheng   +6 more
wiley   +1 more source

Association of Hydroquinone with Nail Discoloration: A Case Report. [PDF]

Case Rep Dermatol
Zaminski DH, Stoll JR, Lipner SR.
europepmc   +1 more source

Spotlight: What's New in JEADV – Editor‐in‐Chief's Selection

JEADV Clinical Practice, Volume 5, Issue 2, Page 367-372, June 2026.
Carle Paul
wiley   +1 more source

Comparison of the Efficacy of Kligman's Formula Combined With 30% Topical Metformin Versus Kligman's Formula Alone in the Treatment of Melasma

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Melasma is a common hyperpigmentation disorder primarily affecting women, influenced by ultraviolet exposure, hormones, and genetics. Kligman's formula is a first‐line therapy, but emerging evidence suggests that topical metformin, an antidiabetic with antimelanogenic effects, may enhance treatment outcomes.
Fariba Iraji, Fatemeh Mokhtari, Zeinab Kassab, Sarah Seyedyousefi, Jaleh Varshosaz   +4 more
wiley   +1 more source